KIORA PHARMACEUTICALS INC Quarterly Operating Income (Loss) in USD from Q2 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Kiora Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2016 to Q3 2024.
  • Kiora Pharmaceuticals Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$3.6M, a 39.1% increase year-over-year.
  • Kiora Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was $4.96M.
  • Kiora Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was -$12.6M, a 2.25% decline from 2022.
  • Kiora Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$12.3M, a 13.5% increase from 2021.
  • Kiora Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$14.2M, a 107% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.96M -$3.6M +$2.32M +39.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $2.64M -$2.54M +$88.1K +3.35% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $2.55M $13.2M +$15.1M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$12.6M -$2.12M +$516K +19.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 -$13.1M -$5.92M -$2.22M -59.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$10.9M -$2.63M -$231K -9.62% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$10.7M -$1.92M +$1.65M +46.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$12.3M -$2.63M +$3.74M +58.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 -$16M -$3.7M -$668K -22% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$15.4M -$2.4M +$417K +14.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$15.8M -$3.57M -$1.56M -77.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$14.2M -$6.37M -$5.2M -445% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$9.03M -$3.04M -$1.03M -51.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$8.01M -$2.82M -$1.1M -63.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$6.91M -$2.01M -$39.5K -2.01% Jan 1, 2021 Mar 31, 2021 10-Q 2022-07-08
Q4 2020 -$6.87M -$1.17M Oct 1, 2020 Dec 31, 2020 10-K/A 2022-07-07
Q3 2020 -$2.01M +$1.44M +41.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$1.72M +$148K +7.93% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$1.97M -$2.8M -338% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q3 2019 -$6.98M -$3.45M -$273K -8.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$6.71M -$1.87M +$929K +33.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$7.64M $829K +$3.21M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$10.8M -$2.49M Oct 1, 2018 Dec 31, 2018 10-K 2019-03-01
Q3 2018 -$3.18M +$962K +23.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$2.8M +$528K +15.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$2.38M +$541K +18.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q3 2017 -$4.14M -$763K -22.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$3.33M +$499K +13.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$2.92M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q3 2016 -$3.38M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$3.83M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.